scispace - formally typeset
Open AccessJournal Article

Establishment and characterization of a human prostatic carcinoma cell line (PC-3).

M E Kaighn, +4 more
- 01 Jul 1979 - 
- Vol. 17, Iss: 1, pp 16-23
TLDR
The establishment, characterization, and tumorigenicity of a new epithelial cell line (PC-3) from a human prostatic adenocarcinoma metastatic to bone is reported, which should be useful in investigating the biochemical changes in advanced prostatic cancer cells and in assessing their response to chemotherapeutic agents.
Abstract
The establishment, characterization, and tumorigenicity of a new epithelial cell line (PC-3) from a human prostatic adenocarcinoma metastatic to bone is reported The cultured cells show anchorage-independent growth in both monolayers and in soft agar suspension and produce subcutaneous tumors in nude mice Culture of the transplanted tumor yielded a human cell line with characteristics identical to those used initially to produce the tumor PC-3 has a greatly reduced dependence upon serum for growth when compared to normal prostatic epithelial cells and does not respond to androgens, glucocorticoids, or epidermal or fibroblast gowth factors Karyotypic analysis by quinacrine banding revealed the cells to be completely aneuploid with a modal chromosome number in the hypotriploid range At least 10 distinctive marker chromosomes were identified The overall karyotype as well as the marker chromosomes are distinct from those of the HeLa cell Electron microscopic studies revealed many features common to neoplastic cells of epithelial origin including numerous microvilli, junctional complexes, abnormal nuclei and nucleoli, abnormal mitochondria, annulate lamellae, and lipoidal bodies Overall, the functional and morphologic characteristics of PC-3 are those of a poorly-differentiated adenocarcinoma These cells should be useful in investigating the biochemical changes in advanced prostatic cancer cells and in assessing their response to chemotherapeutic agents

read more

Citations
More filters
Journal ArticleDOI

Metformin targets c-MYC oncogene to prevent prostate cancer.

TL;DR: The novel findings suggest that by downregulating c-myc, metformin can act as a chemopreventive agent to restrict prostatic neoplasia initiation and transformation, and may inhibit prostate intraepithelialNeoplasia transforming to cancer lesion via reducing c-MYC, an 'old' overexpressed oncogene.
Journal ArticleDOI

Model systems of prostate cancer: Uses and limitations

TL;DR: The properties of the prostate cancer model systems in use are summarized and their utility and limitations are defined to guide the investigator seeking models with which to test specific hypotheses pertaining to prostate cancer.
Journal ArticleDOI

The inflammatory microenvironment of the aging prostate facilitates cellular proliferation and hypertrophy

TL;DR: The transcriptome of the aging prostate stroma is characterized by the up-regulation of several genes that encode secreted inflammatory mediators, including secreted CXC-type chemokines, which may account for the low-level, but cumulative, proliferation of both epithelial and fibroblastic/myofibroblast cell types that characterizes the aging-associated development of benign prostatic hypertophy.
Journal ArticleDOI

Engrailed-2 (EN2): A Tumor Specific Urinary Biomarker for the Early Diagnosis of Prostate Cancer

TL;DR: Urinary EN2 is a highly specific and sensitive candidate biomarker of prostate cancer, with a sensitivity of 66% and a specificity of 88.2%, without requirement for DRE.
Related Papers (5)